The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1572
ISSUE1572
May 20, 2019
Inhaled Levodopa (Inbrija) for Parkinson's Disease
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Inhaled Levodopa (Inbrija) for Parkinson's Disease
May 20, 2019 (Issue: 1572)
The FDA has approved Inbrija (Acorda), an orally
inhaled dry-powder formulation of levodopa, for
intermittent treatment of "off" episodes in patients
with Parkinson's disease (PD) being treated with
carbidopa/levodopa (Sinemet, and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.